More Nexalis Therapeutics Limited news
Nexalis Therapeutics LimitedASX: NX1

LSH enters $50Bn Global Medicinal Cannabis market

May 1, 2017 at 12:24 AM EDT · Issued by Nexalis Therapeutics Limited

Filed with ASX · May 1, 2017 at 12:24 AM EDT · 2 pages · English

On 6ix: 6ix.com/news/lsh-enters-dollar50bn-global-medicinal-cannabis-market

Nexalis Therapeutics Limited on 6ix

Earlier from Nexalis Therapeutics

  • Update on Medicinal Cannabis opportunitiesApr 4, 2017
  • Exploring opportunities in Medicinal CannabisMar 27, 2017
  • Lifespot Health wins major contract & strategic b2b partnerMar 7, 2017
  • Lifespot Health to enter coagulation home monitoring marketFeb 2, 2017
  • Market UpdateJan 15, 2017

Later from Nexalis Therapeutics

  • Business & Operational UpdateMay 18, 2017
  • Digital Health Consortium Formed To Target $3.5B MarketJul 28, 2017
  • Lifespot Signs Global Agreement With BeurerSep 7, 2017
  • Lifespot Health restructures its Business and BoardNov 1, 2017
  • New Patient Self-Management System LaunchedMar 20, 2018
All Nexalis Therapeutics news releases↗

Follow Nexalis Therapeutics into a list and get an email when it puts out news.

Follow Nexalis Therapeutics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer